These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7154725)

  • 1. [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia].
    Ribera JM; Urbano-Márquez A; Arroyo V; Bosch J; Estruch R; Grau JM
    Med Clin (Barc); 1982 Dec 1-31; 79(10):468-71. PubMed ID: 7154725
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal hypertension complicating myelofibrosis: reversal following splenectomy.
    Lukie BE; Card RT
    Can Med Assoc J; 1977 Oct; 117(7):771-2. PubMed ID: 907949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agnogenic myeloid metaplasia with portal hypertension.
    Colker JL; Baker WG; Kolodny M
    Gastrointest Endosc; 1968 Nov; 15(2):70 passim. PubMed ID: 5723438
    [No Abstract]   [Full Text] [Related]  

  • 4. A patient with myelofibrosis complicated by refractory ascites and portal hypertension: to tips or not to tips? A case report with discussion of the mechanism of ascites formation.
    Wiest R; Strauch U; Wagner H; Strotzer M; Woenckhaus M; Schröder G; Schölmerich J; Lock G
    Scand J Gastroenterol; 2004 Apr; 39(4):389-94. PubMed ID: 15125474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myeloid metaplasia and portal hypertension].
    Escartin Marín P; García Plaza A; Chartar Barrios C; Anaya Mune A; Rodrígo Sáez L; Milicua Salamero JM
    Rev Clin Esp; 1972 Jul; 126(1):29-34. PubMed ID: 5080186
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascites revealing peritoneal and hepatic extramedullary hematopoiesis with peliosis in agnogenic myeloid metaplasia: case report and review of the literature.
    Lioté F; Yeni P; Teillet-Thiebaud F; Barge J; Devars Du Mayne JF; Flamant Y; Molas G; Carbon C
    Am J Med; 1991 Jan; 90(1):111-7. PubMed ID: 1986577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature and incidence of liver involvement in agnogenic myeloid metaplasia.
    Ligumski M; Polliack A; Benbassat J
    Scand J Haematol; 1978 Aug; 21(2):81-93. PubMed ID: 308689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Portal hypertension and myeloid metaplasia: apropos of a case treated surgically].
    Mongin M; Assadourian R
    Mars Med; 1969; 106(12):1065-8. PubMed ID: 5398397
    [No Abstract]   [Full Text] [Related]  

  • 9. Endoscopic variceal ligation for portal hypertension due to myelofibrosis with myeloid metaplasia.
    Nikolaidis N; Giouleme O; Sileli M; Tziomalos K; Grammatikos N; Garipidou V; Eugenidis N
    Eur J Haematol; 2004 May; 72(5):379-80. PubMed ID: 15059078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperdynamic form of portal hypertension in patients with myeloid metaplasia].
    Kunst VA
    Folia Med Neerl; 1967; 10(6):197-8. PubMed ID: 5590980
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys.
    Schnuelle P; Waldherr R; Lehmann KJ; Woenckhaus J; Back W; Niemir Z; van der Woude FJ
    Clin Nephrol; 1999 Oct; 52(4):256-62. PubMed ID: 10543329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases.
    Abu-Hilal M; Tawaker J
    World J Gastroenterol; 2009 Jul; 15(25):3128-33. PubMed ID: 19575492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myeloid splenomegaly with lymph node involvement and portal hypertension].
    Bousser J; Delarue J; Bilski-Pasquier G; Zittoun DR; Gluckmann E
    Presse Med (1893); 1968 Oct; 76(39):1869-70. PubMed ID: 5738633
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of hepatic hematopoiesis with radioactive gold (198Au).
    Turner AR; Gummerman LW; Boggs DR
    J Nucl Med; 1985 Apr; 26(4):366-7. PubMed ID: 2984361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic study of the portal system in 6 cases of myeloid metaplasia].
    Escartín Marin P; Arenas Mirave JI; Boixeda D; Hernández Ranz F; García Plaza A
    Rev Clin Esp; 1977 May; 145(4):271-3. PubMed ID: 866750
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver sinusoids and sinusoidal cells in patients with agnogenic myeloid metaplasia.
    Roux D; Bioulac-Sage P; Merlio JP; Lamouliatte H; Quinton A; Balabaud C
    J Clin Gastroenterol; 1987 Aug; 9(4):483-7. PubMed ID: 3655281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal chemotherapy with cytosine arabinoside in agnogenic myelofibrosis with myeloid metaplasia and ascites due to peritoneal extramedullary hematopoiesis.
    Stahl RL; Hoppstein L; Davidson TG
    Am J Hematol; 1993 Jun; 43(2):156-7. PubMed ID: 8342549
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites progressing to an abdominal mass due to extramedullary hematopoiesis in a patient with agnogenic myeloid metaplasia (AMM).
    Marshall JB; Burnett DA; Anderson JC; Zetterman RK
    Dig Dis Sci; 1983 Oct; 28(10):912-7. PubMed ID: 6617403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ascites caused by portal hypertension in a patient with chronic myelomonocytic leukemia].
    Pamplona J; Sábat M; Sancho Poch FJ; Monés J
    Rev Esp Enferm Dig; 1996 Feb; 88(2):151-3. PubMed ID: 8664073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.